4//SEC Filing
Faleck Herbert J 4
Accession 0001127602-18-000822
CIK 0001472091other
Filed
Jan 2, 7:00 PM ET
Accepted
Jan 3, 6:53 PM ET
Size
4.9 KB
Accession
0001127602-18-000822
Insider Transaction Report
Form 4
Faleck Herbert J
Chief Medical Officer
Transactions
- Award
Stock Option (Right To Purchase)
2018-01-02+50,000→ 50,000 totalExercise: $10.10From: 2019-01-02Exp: 2028-01-02→ Common Stock (50,000 underlying)
Documents
Issuer
Edge Therapeutics, Inc.
CIK 0001472091
Entity typeother
Related Parties
1- filerCIK 0001652994
Filing Metadata
- Form type
- 4
- Filed
- Jan 2, 7:00 PM ET
- Accepted
- Jan 3, 6:53 PM ET
- Size
- 4.9 KB